ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Illinois Jury Awards $45 Million in Mesothelioma Case Against Johnson & Johnson, Kenvue, Inc.

A jury in the Circuit Court of Cook County in Chicago found Johnson & Johnson (NYSE: JNJ) and two subsidiaries liable in the asbestos-related death of a mother and grandmother, and awarded her family $45 million in damages.

The jury concluded that Theresa Garcia’s lifelong use of talc-based Johnson’s Baby Powder and other products was the cause of her mesothelioma, an always-fatal cancer of the lining of the lungs caused by exposure to asbestos. Laboratory testing has shown the presence of asbestos in some samples of Johnson’s Baby Powder.

The trial follows two Johnson & Johnson bankruptcy filings that stayed litigation in this and thousands of other cases involving asbestos and talc.

“After years of delay caused by Johnson & Johnson’s bad faith abuse of the bankruptcy system, we are so grateful that the jury saw through Johnson & Johnson’s, Johnson & Johnson Holdco, Inc.’s and Kenvue, Inc.’s deceptions. The defendants knew that talc contains asbestos impurities that were mined and put in the bottles of baby powder J&J sold,” said attorney Jessica Dean of Dallas’ Dean Omar Branham Shirley who represents Ms. Garcia’s family along with the firm’s Ben Adams and Mark Buha, and Christian Luciano Santiago of Vogelzang Law. “Not only did the defendants’ negligence and deceit cheat loyal customers like Theresa, but their deception has ultimately robbed a family of their mother.”

Throughout her life, Ms. Garcia, a mother of six from Chicago, frequently used talc-based Johnson’s Baby Powder on herself and, later when she became a mother, on her children.

Attorneys for Ms. Garcia demonstrated that the talc-containing products manufactured by Johnson & Johnson also contained asbestos fibers. Experts explained that the daily use and amount inhaled by Ms. Garcia throughout her life led to her mesothelioma. She was diagnosed in January 2020 and died in July of that year.

“Ms. Garcia’s case was delayed by several years when Johnson & Johnson filed two bad faith bankruptcies in an attempt to avoid the decades of liability it now faces,” said Mr. Adams. “During the pendency of those bad faith bankruptcies, Johnson & Johnson engaged in a corporate shell game creating Kenvue, Inc. (NYSE: KVUE) The Cook County jury found that Kenvue is responsible for 70% of Mrs. Garcia’s injuries and death as the successor in interest to Johnson & Johnson. The jury also put 15% of the responsibility on Johnson & Johnson and 15% on Johnson & Johnson Holdco, Inc.”

Ms. Garcia is survived by her children Stephanie Salcedo, Vanessa Garcia, Edward Cerda, Jr., Jazmine Cerda, Caressa Garcia, and Anyssa Cerda.

The case is Stephanie Salcedo et al., vs Cyprus Amax Minerals Company, et al., Case No. 2020 L 004505 in Circuit Court in Cook County, Illinois.

About Dean Omar Branham Shirley, LLP

Dean Omar Branham Shirley, LLP is a national and recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of the irresponsible conduct of others. For more information, please visit http://www.dobslegal.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.